List view / Grid view

Dr. Torsten Neuefeind

 

news

Oncology collaboration: Proteros & MSD to find epigenetic target

Proteros has entered into a second research agreement with Merck…

22 November 2016 | By Niamh Louise Marriott, Digital Content Producer

Proteros has entered into a second research agreement with Merck aimed at developing small molecule compounds against an additional epigenetic target...